ALMUDENA CASCAJERO DIAZ

Técnico Superior de Actividades Técnicas y Profesionales

Instituto de Salud Carlos III

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

LinkedIn

Google Scholar

About

Almudena Cascajero Diaz serves as Técnico Superior de Actividades Técnicas y Profesionales at Instituto de Salud Carlos III in Spain. Her research focuses on immunogenicity related to COVID-19 vaccines, particularly in relation to SARS-CoV-2 variants and the immune response in different populations. Recent publications explore the effects of vaccination regimens, including the characteristics of Legionella strains and their clinical implications.

Articles (9)

Characterisation of <i>Legionella</i> Clinical Isolates in Spain from 2012 to 2022.

Year:

2024

Fulminant septic shock due to community-acquired pneumonia caused by Legionella pneumophila SG1 Olda OLDA ST1. Case report

Year:

2024

Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.

Year:

2024

Longer intervals between SARS‐CoV‐2 infection and mRNA‐1273 doses improve the neutralization of different variants of concern

Year:

2023

Treatment with integrase inhibitors alters SARS‐CoV‐2 neutralization levels measured with HIV‐based pseudotypes in people living with HIV

Year:

2023

Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

Year:

2022

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

Year:

2022

Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19

Year:

2022

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Year:

2021

Collaborators (10)

Fernando González-Camacho

Instituto de Salud Carlos III

SPAIN

Antonio Portolés-Pérez

Profesor Titular Vinculado

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

Alberto M. Borobia

-

SPAIN

Carla Pérez-Ingidua

Profesor Ayudante Doctor

Universidad Complutense de Madrid

SPAIN

Mayte Perez-olmeda

Instituto de Salud Carlos III

SPAIN

Antonio Javier Carcas Sansuán

Permanent Lecturer

medical school universidad autónoma de madrid madrid spain

SPAIN

Miguel Ángel García Garrido

Profesor. Coordinador de Prácticas Clínicas

Universidad Alfonso X el Sabio

SPAIN

Oleguer Parés-Badell

Assistant professor

University of Barcelona

SPAIN

Francisco Díez-Fuertes

Instituto de Salud Carlos III

SPAIN

Ana Ascaso

Associate Professor in Health Sciences

Universidad Complutense de Madrid

SPAIN

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI